Acadian Asset Management’s Allena Pharmaceuticals ALNA Stock Holding History

Acadian Asset Management’s Portfolio ALNA Stock Details ALNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-237,610	Closed	-$4K	–	1974
2022 Q3	$4K	Sell	237,610 -1,013,378	-81%	-$135K	﹤0.01%	1646
2022 Q2	$239K	Buy	+1,250,988	New	+$194K	﹤0.01%	1157
2020 Q3	–	Sell	-17,628	Closed	-$28K	–	2430
2020 Q2	$28K	Buy	+17,628	New	+$29.6K	﹤0.01%	2067
2019 Q4	–	Sell	-9,345	Closed	-$37K	–	2127
2019 Q3	$37K	Buy	+9,345	New	+$40.1K	﹤0.01%	1653
2019 Q2	–	Sell	-15,070	Closed	-$106K	–	2112
2019 Q1	$106K	Buy	15,070 +251	+2%	+$1.82K	﹤0.01%	1502
2018 Q4	$81K	Hold	14,819	–	–	﹤0.01%	1319
2018 Q3	$159K	Sell	14,819 -3,720	-20%	-$40.9K	﹤0.01%	1113
2018 Q2	$242K	Buy	+18,539	New	+$267K	﹤0.01%	1036

Acadian Asset Management's ALNA Position: Q4 2022 in Review

Acadian Asset Management sold out of Allena Pharmaceuticals (ALNA) in Q4 2022, closing a stake of 237,610 shares — an estimated $4K sold.

Acadian Asset Management first reported a position in ALNA in Q2 2018 and held it in 8 quarters. The position peaked at $242K in Q2 2018. 0 funds tracked by Wall St. Rank hold ALNA as of Q4 2022.

Acadian Asset Management reported no remaining Allena Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Acadian Asset Management sold 237,610 Allena Pharmaceuticals shares in Q4 2022, an estimated $4K.
Acadian Asset Management first reported a position in Allena Pharmaceuticals in Q2 2018 and held it in 8 quarters.
Acadian Asset Management's Allena Pharmaceuticals position peaked at $242K in Q2 2018.
0 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q4 2022.

Based on Acadian Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.